Septerna to Present at Jefferies Global Healthcare Conference

Rhea-AI Summary

Septerna (NASDAQ: SEPN), a biotechnology company focused on G protein-coupled receptor (GPCR) drug discovery, has announced its participation in the upcoming Jefferies Global Healthcare Conference. The company's CEO and Co-founder, Jeffrey Finer, M.D., Ph.D., will deliver a presentation on Thursday, June 5, 2025, at 3:45 p.m. ET in New York. Interested parties can access a live webcast of the presentation through the company's website or the provided link, with the recording remaining available for at least 30 days afterward.

SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., Chief Executive Officer and Co-founder of Septerna, will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 3:45 p.m. ET in New York.

A live webcast of the presentation will be available here and in the investors section of the company’s website at www.septerna.com. The webcast will be archived for at least 30 days following the presentation.

About Septerna
Septerna, Inc. is a biotechnology company pioneering a new era of GPCR drug discovery powered by its proprietary Native Complex Platform™. Its industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of its deep pipeline of oral small molecule product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Septerna was launched by preeminent drug discovery company builders and scientific leaders in the biochemistry, structural biology, and pharmacology of GPCRs. For more information, please visit www.septerna.com.

Investor Contact:
Renee Leck
THRUST Strategic Communications
renee@thrustsc.com

FAQ

When is Septerna (SEPN) presenting at the Jefferies Global Healthcare Conference 2025?

Septerna will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 3:45 p.m. ET in New York.

Who will represent Septerna (SEPN) at the Jefferies Healthcare Conference 2025?

Jeffrey Finer, M.D., Ph.D., Chief Executive Officer and Co-founder of Septerna, will present at the conference.

How can investors watch Septerna's (SEPN) presentation at the Jefferies Conference?

Investors can watch the live webcast through the company's website (www.septerna.com) in the investors section. The webcast will be archived for at least 30 days.

What is Septerna's (SEPN) main business focus?

Septerna is a biotechnology company that specializes in G protein-coupled receptor (GPCR) drug discovery.